Sophia Genetics Sa · NASDAQ:SOPH
Puylaert Kevin sold 216 Sophia Genetics Sa shares (Form 4)
Traded Jul 6, 2026 · Filed Jul 7, 2026
On Jul 6, 2026, Puylaert Kevin (Chief Sales Officer) sold 216 Sophia Genetics Sa shares at an average US$5.04 for US$1,088, leaving 147,948 shares. Filed Jul 7, 2026 (Form 4).
- Sold
- 216 shares
- Price
- US$5.04 average (US$5.03 to US$5.09)
- Value
- US$1,088
- Holding after
- 147,948 shares
- Trading plan
- No
- Role
- Chief Sales Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Ordinary Shares | Sale | 138 | US$5.03 | 148,026 | Direct |
| Jul 6, 2026 | Ordinary Shares | Sale | 47 | US$5.03 | 147,979 | Direct |
| Jul 6, 2026 | Ordinary Shares | Sale | 31 | US$5.09 | 147,948 | Direct |
Source
Related
- Sophia Genetics Sa
- Puylaert Kevin
- Sophia Genetics Sa shareholders
- Form 4 · Puylaert Kevin · Oct 7, 2026
- Form 4 · Puylaert Kevin · May 20, 2026
- Form 4 · Puylaert Kevin · Apr 21, 2026
- Form 4/A · Puylaert Kevin · Apr 8, 2026
- Form 4 · Puylaert Kevin · Apr 8, 2026
- Form 4 · Xu Zhenyu · Oct 14, 2026
- Form 4 · Menu Philippe · Oct 14, 2026
- Form 4 · Camblong Jurgi · Oct 14, 2026
- Form 4 · Menu Philippe · Oct 7, 2026
- Form 4 · Valente Manuela · Oct 7, 2026